{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:33:33Z","timestamp":1787776413586,"version":"build-2784847793"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jgar.2021.11.008","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T02:39:14Z","timestamp":1638931154000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2909-0797","authenticated-orcid":false,"given":"Florian","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Nicolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-0302","authenticated-orcid":false,"given":"Riccardo","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Gales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Grigoryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hooton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Lopardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-3912","authenticated-orcid":false,"given":"Aruna","family":"Poojary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7048-8086","authenticated-orcid":false,"given":"David A.","family":"Talan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Tir\u00e1n","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-2868","authenticated-orcid":false,"given":"Mark H.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.11.008_bib0001","series-title":"EAU guidelines on urological infections","year":"2020"},{"key":"10.1016\/j.jgar.2021.11.008_bib0002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","article-title":"Epidemiology, definition and treatment of complicated urinary tract infections","volume":"17","author":"Wagenlehner","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0003","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.3399\/bjgp15X686965","article-title":"Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey","volume":"65","author":"Butler","year":"2015","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0004","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","author":"Gupta","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0005","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1017\/S0950268818003369","article-title":"Associations between antibiotic prescriptions and recurrent urinary tract infections in female college students","volume":"147","author":"Rich","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/antibiotics3010098","article-title":"Uncomplicated urinary tract infections in women in a Sao Paulo quaternary care hospital: bacterial spectrum and susceptibility patterns","volume":"3","author":"Hisano","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2021.11.008_bib0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2015.10.014","article-title":"Obesity and recurrent urinary tract infections in premenopausal women: a retrospective study","volume":"41","author":"Nseir","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0008","doi-asserted-by":"crossref","first-page":"b5633","DOI":"10.1136\/bmj.b5633","article-title":"Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study","volume":"340","author":"Little","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0009","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.3399\/bjgp17X693641","article-title":"Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study","volume":"67","author":"Butler","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/23744235.2020.1834138","article-title":"Uncomplicated urinary tract infection in primary health care: presentation and clinical outcome","volume":"53","author":"Kornf\u00e4lt Isberg","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jgar.2021.11.008_bib0011","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0012","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","article-title":"Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections","volume":"50","author":"Kang","year":"2018","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0013","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jiac.2017.02.002","article-title":"JAID\/JSC guidelines for clinical management of infectious disease 2015\u2014urinary tract infection\/male genital infection","volume":"23","author":"Yamamoto","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0014","first-page":"2827","article-title":"Consensus of Chinese experts on the diagnosis and treatment of female urinary tract infection","volume":"97","year":"2017","journal-title":"Natl Med J Chin"},{"key":"10.1016\/j.jgar.2021.11.008_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00192-019-04079-5","article-title":"Latin American consensus on uncomplicated urinary tract infection\u20142018","volume":"31","author":"Haddad","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jgar.2021.11.008_bib0016","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s10096-019-03655-3","article-title":"Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period","volume":"38","author":"Van Driel","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12879-019-3785-x","article-title":"Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment","volume":"19","author":"Kornf\u00e4lt Isberg","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","article-title":"Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia","volume":"17","author":"Ny","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2021.11.008_bib0019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jac\/dkw399","article-title":"Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population","volume":"72","author":"Mulder","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0020","doi-asserted-by":"crossref","first-page":"e00862","DOI":"10.1128\/AAC.00862-20","article-title":"Escherichia coli resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection: a systematic review","volume":"64","author":"Stapleton","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0021","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study","volume":"24","author":"Stewardson","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2021.11.008_bib0022","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp20X711533","article-title":"Antibiotic resistance of uropathogenic Escherichia coli and ESBL prevalence in general practice patients over 10 years","volume":"70","author":"van Driel","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0023","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/cid\/ciab560","article-title":"Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011\u20132019: rising ESBL strains and impact on management","volume":"73","author":"Kaye","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12879-017-2296-x","article-title":"Antimicrobial susceptibilities of aerobic and facultative Gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2967260","article-title":"The clinical significance of high antimicrobial resistance in community-acquired urinary tract infections","volume":"2020","author":"Zavala-Cerna","year":"2020","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100716","article-title":"Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital","volume":"36","author":"Muhammad","year":"2020","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0027","series-title":"FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects","year":"2016"},{"key":"10.1016\/j.jgar.2021.11.008_bib0028","series-title":"FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions","year":"2018"},{"key":"10.1016\/j.jgar.2021.11.008_bib0029","series-title":"Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone fluoroquinolone antibiotics","year":"2019"},{"key":"10.1016\/j.jgar.2021.11.008_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","article-title":"Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)","volume":"18","author":"Wagenlehner","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jgar.2021.11.008_bib0031","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajog.2016.07.040","article-title":"Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis","volume":"215","author":"Price","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jgar.2021.11.008_bib0032","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women (review)","volume":"2004","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2021.11.008_bib0033","doi-asserted-by":"crossref","first-page":"h6888","DOI":"10.1136\/bmj.h6888","article-title":"Which treatment strategy for women with symptoms of urinary tract infection?","volume":"351","author":"Bjerrum","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287218814382","article-title":"Risk factors and predisposing conditions for urinary tract infection","volume":"11","author":"Storme","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0035","doi-asserted-by":"crossref","first-page":"ITC49","DOI":"10.7326\/AITC201710030","article-title":"Urinary tract infection","volume":"167","author":"Gupta","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0036","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0037","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/jsm.12686","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"11","author":"Portman","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0038","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/iju.12396","article-title":"Enigma of urethral pain syndrome: why are there so many ascribed etiologies and therapeutic approaches","volume":"21","author":"Phillip","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0039","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bjid.2020.04.002","volume":"24","author":"de Rossi","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0041","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2296-11-78","article-title":"Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs","volume":"11","author":"Giesen","year":"2010","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000493509","article-title":"Reliability of symptom-based diagnosis of uncomplicated cystitis","volume":"102","author":"Alidjanov","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.jgar.2021.11.008_bib0043","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1464-410X.2005.05630.x","article-title":"Validation of patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire","volume":"96","author":"Clayson","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.jgar.2021.11.008_bib0044","first-page":"11","article-title":"The presentation, diagnosis, and treatment of sexually transmitted infections","volume":"113","author":"Wagenlehner","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jgar.2021.11.008_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2017.12.231","article-title":"Diagnosis and treatment of urinary tract infections across age groups","volume":"219","author":"Chu","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8642628","article-title":"The effectiveness of dipstick for the detection of urinary tract infection","volume":"2019","author":"Dadzie","year":"2019","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0047","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1302186","article-title":"Voided midstream urine culture and acute cystitis in premenopausal women","volume":"369","author":"Hooton","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0048","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrurol.2017.20","article-title":"New and developing diagnostic technologies for urinary tract infections","volume":"14","author":"Davenport","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0049","first-page":"52","article-title":"A rapid, point-of-care antibiotic susceptibility test for urinary tract infections","volume":"69","author":"Toosky","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0050","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10096-020-03855-2","article-title":"Clinical impact of rapid susceptibility testing on Mueller\u2013Hinton Rapid-SIR directly from urine specimens","volume":"39","author":"Pilmis","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0051","series-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFUguideline (2019)","year":"2019"},{"key":"10.1016\/j.jgar.2021.11.008_bib0052","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0053","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women. A randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2021.11.008_bib0054","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"issue":"10","key":"10.1016\/j.jgar.2021.11.008_bib0055","article-title":"Antimicrobial agents for treating uncomplicated urinary tract infection in women (review)","author":"Zalmanovici Trestioreanu","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2021.11.008_bib0056","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","article-title":"Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials","volume":"65","author":"Falagas","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0057","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","article-title":"Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents","volume":"132","author":"Bader","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0058","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jiph.2019.05.012","article-title":"Oral treatment options for patients with urinary tract infections caused by extended spectrum \u03b2-lactamase (ESBL) producing Enterobacteriaceae","volume":"12","author":"Raja","year":"2019","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgar.2021.11.008_bib0059","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diagmicrobio.2017.04.007","article-title":"Pharmacodynamic activity of fosfomycin simulating urinary concentrations achieved after a single 3-g oral dose versus Escherichia coli using an in vitro model","volume":"88","author":"Zhanel","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ijmr.IJMR_2086_17","article-title":"Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections","volume":"149","author":"Amladi","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2021.11.008_bib0061","doi-asserted-by":"crossref","first-page":"ofy297","DOI":"10.1093\/ofid\/ofy297","article-title":"Antimicrobial susceptibility trends observed in urinary pathogens obtained from New York state","volume":"5","author":"Rank","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0062","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1678-9946201658002","article-title":"Antibiotic resistance patterns of urinary tract infections in a Northeastern Brazilian capital","volume":"58","author":"Cunha","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jgar.2021.11.008_bib0063","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jiac.2019.02.021","volume":"25","author":"Hayami","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0064","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0976-9668.210012","article-title":"Isolation and antibiotic susceptibility pattern of Escherichia coli from urinary tract infections in a tertiary care hospital of North Eastern Karnataka","volume":"8","author":"Kulkarni","year":"2017","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.urology.2019.11.009","article-title":"Algorithms using previous resistance, prior antimicrobial prescriptions, and patient place of residence enhance empirical therapy for women with uncomplicated urinary tract infections","volume":"137","author":"Cohen","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.jgar.2021.11.008_bib0066","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4103\/jfmpc.jfmpc_970_19","article-title":"Susceptibility pattern of oral antimicrobials in uncomplicated UTI: does fosfomycin still stand effective?","volume":"9","author":"Batra","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.jgar.2021.11.008_bib0067","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3947\/ic.2017.49.3.184","article-title":"Antimicrobial susceptibilities of Enterobacteriaceae in community-acquired urinary tract infections during a 5-year period: a single hospital study in Korea","volume":"49","author":"Park","year":"2017","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0068","doi-asserted-by":"crossref","first-page":"h6544","DOI":"10.1136\/bmj.h6544","article-title":"Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial","volume":"351","author":"Gagyor","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002569","article-title":"Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women\u2014a double-blind, randomized, non-inferiority trial","volume":"15","author":"Vik","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0070","doi-asserted-by":"crossref","first-page":"j4784","DOI":"10.1136\/bmj.j4784","article-title":"Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double-blind trial","volume":"359","author":"Kronenberg","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0071","series-title":"SIGN 160: Management of suspected bacterial lower urinary tract infection in adult women","year":"2020"},{"key":"10.1016\/j.jgar.2021.11.008_bib0072","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000493368","volume":"101","author":"Wagenlehner","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.jgar.2021.11.008_bib0073","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cmi.2021.05.032","article-title":"Herbal treatment with uva ursi versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial","volume":"27","author":"Gagyor","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11655-017-2960-4","article-title":"Treatment of uncomplicated recurrent urinary tract infection with Chinese medicine formula: a randomized controlled trial","volume":"25","author":"Liu","year":"2019","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jgar.2019.10.023","article-title":"Prediction of trimethoprim\/sulfamethoxazole resistance in community-onset urinary tract infections","volume":"21","author":"DeMarsh","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2021.11.008_bib0076","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00345-020-03464-w","article-title":"Adverse effects of chronic nitrofurantoin therapy in women with recurrent urinary tract infections in an outpatient setting","volume":"39","author":"Maredia","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0077","first-page":"1173","article-title":"Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial","volume":"25","author":"Constantini","year":"2014","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jgar.2021.11.008_bib0078","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(17)32837-9","article-title":"Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women","volume":"152","author":"Pfau","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0079","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-5347(01)65087-0","article-title":"Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women","volume":"157","author":"Melekos","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0080","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1093\/cid\/ciab116","article-title":"The benefits and harms of antibiotic prophylaxis for urinary tract infection in older adults","volume":"73","author":"Langford","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.jgar.2021.11.008_bib0081","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"Collateral damage\u2019 from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0082","doi-asserted-by":"crossref","first-page":"344.e1","DOI":"10.1016\/j.cmi.2014.11.016","article-title":"Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota","volume":"21","author":"Stewardson","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0083","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2296-15-162","article-title":"How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum","volume":"15","author":"Flower","year":"2014","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0084","doi-asserted-by":"crossref","first-page":"c279","DOI":"10.1136\/bmj.c279","article-title":"Women's views about management and cause of urinary tract infection: qualitative interview study","volume":"340","author":"Leydon","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2021.11.008_bib0085","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.3399\/bjgp20X708125","article-title":"Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis","volume":"70","author":"Scott","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jgar.2021.11.008_bib0086","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cid\/ciq073","article-title":"Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial","volume":"52","author":"Barbosa-Cesnik","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0087","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mayocp.2011.10.006","article-title":"Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial","volume":"87","author":"Stapleton","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jgar.2021.11.008_bib0088","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3945\/ajcn.116.130542","article-title":"Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection","volume":"103","author":"Maki","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jgar.2021.11.008_bib0089","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/dkn489","article-title":"Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women","volume":"63","author":"McMurdo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0090","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archinternmed.2011.306","article-title":"Cranberries vs antibiotics to prevent urinary tract infections. A randomized double-blind noninferiority trial in premenopausal women","volume":"171","author":"Beerepoot","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0091","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","volume":"329","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0092","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women","volume":"180","author":"Eriksen","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0093","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.eururo.2004.12.009","article-title":"A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections","volume":"47","author":"Bauer","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0094","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-5347(17)35648-3","article-title":"Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study","volume":"150","author":"Schulman","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1464-410X.1990.tb14649.x","article-title":"Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection","volume":"65","author":"Tammen","year":"1990","journal-title":"Br J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0096","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/01.ju.0000075094.54767.6e","article-title":"Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections","volume":"170","author":"Uehling","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0097","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.11.093","article-title":"Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial","volume":"177","author":"Hopkins","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0098","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0022-5347(01)64671-8","article-title":"Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial","volume":"157","author":"Uehling","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0099","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1473-3099(18)30803-X","article-title":"Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial","volume":"19","author":"Frenck","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0101","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","article-title":"Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study","volume":"17","author":"Eldridge","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","article-title":"d-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial","volume":"32","author":"Kranjcec","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)54386-4","article-title":"Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate","volume":"126","author":"Brumfitt","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0104","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0022-5347(17)51709-7","article-title":"Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine","volume":"130","author":"Brumfitt","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0105","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/cid\/cir183","article-title":"Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection","volume":"52","author":"Stapleton","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0106","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","article-title":"Lactobacilli vs antibiotics to prevent urinary tract infections. A randomized, double-blind, noninferiority trial in postmenopausal women","volume":"172","author":"Beerepoot","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0107","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1185\/030079907X233089","volume":"23","author":"Albrecht","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jgar.2021.11.008_bib0108","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/pds.5018","article-title":"Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning","volume":"29","author":"Bratsman","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jgar.2021.11.008_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105966","article-title":"Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study","volume":"56","author":"Cai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2021.11.008_bib0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.japh.2019.03.006","article-title":"Development and implementation of a clinical decision support tool for treatment of uncomplicated urinary tract infections in a family medicine resident clinic","volume":"59","author":"Eudaley","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.jgar.2021.11.008_bib0111","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11096-012-9606-6","article-title":"Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns","volume":"34","author":"Slekovec","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jgar.2021.11.008_bib0112","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4212\/cjhp.v67i2.1339","article-title":"Urinary Tract Infections: Leading Initiatives in Selecting Empiric Outpatient Treatment (UTILISE)","volume":"67","author":"Landry","year":"2014","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jgar.2021.11.008_bib0113","doi-asserted-by":"crossref","first-page":"e87899","DOI":"10.1371\/journal.pone.0087899","article-title":"Effect of a stewardship intervention on adherence to uncomplicated cystitis and pyelonephritis guidelines in an emergency department setting","volume":"9","author":"Hecker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.11.008_bib0114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinf.2018.07.001","article-title":"Global access to antibiotics without prescription in community pharmacies: a systematic review and meta-analysis","volume":"78","author":"Auta","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/M19-0505","article-title":"Use of antibiotics without a prescription in the U.S. population. A scoping review","volume":"171","author":"Grigoryan","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0116","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/339812","article-title":"Empiric use of trimethoprim\u2013sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens","volume":"34","author":"Raz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0117","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/339491","article-title":"Prevalence and predictors of trimethoprim\u2013sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan","volume":"34","author":"Brown","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0118","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11255-019-02327-7","article-title":"The clinical rate of antibiotic change following empiric treatment for suspected urinary tract infections","volume":"52","author":"Dokter","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0119","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/jac\/dkl368","article-title":"Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care","volume":"58","author":"McNulty","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0120","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.eururo.2020.06.025","article-title":"Telehealth in urology: a systematic review of the literature: how much can telemedicine be useful during and after the COVID-19 pandemic?","volume":"78","author":"Novara","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.jgar.2021.11.008_bib0121","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.annemergmed.2018.05.006","article-title":"Emergency department urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: many patients have no identifiable risk factor and discordant empiric therapy is common","volume":"72","author":"Frazee","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187832","article-title":"Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014","volume":"12","author":"Samuelsen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2021.11.008_bib0123","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/AAC.03938-14","article-title":"Dissemination of NDM metallo-\u03b2-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012","volume":"59","author":"Biedenbach","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.11.008_bib0124","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0125","doi-asserted-by":"crossref","unstructured":"Kaye KS, Gupta V, Mulgirigama, Joshi AV, Scangarella-Oman NE, Yu K, et al. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: a multicenter evaluation from 2011 to 2019. In: IDWeek 2020 (virtual) [poster 1699]. 10.1093\/ofid\/ofaa439.1877.","DOI":"10.1093\/ofid\/ofaa439.1877"},{"key":"10.1016\/j.jgar.2021.11.008_bib0126","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/ciw396","article-title":"Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens","volume":"63","author":"Walker","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0127","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ajem.2020.11.062","article-title":"Travel to Mexico and uropathogen-antibiotic susceptibility mismatch in the emergency department","volume":"46","author":"Torres","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0128","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s15010-019-01361-y","article-title":"Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland","volume":"47","author":"Plate","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2021.11.008_bib0129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1017\/S0950268817002680","article-title":"Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections","volume":"146","author":"Ukah","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2021.11.008_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","article-title":"A prospective study of risk factors for symptomatic urinary tract infection in young women","volume":"335","author":"Hooton","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001648-200207000-00011","article-title":"Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides","volume":"13","author":"Handley","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.jgar.2021.11.008_bib0132","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/315827","article-title":"Risk factors for recurrent urinary tract infection in young women","volume":"182","author":"Scholes","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2021.11.008_bib0133","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0970-0218.170962","article-title":"Behavioral and psychosocial risk factors associated with first and recurrent cystitis in Indian women: a case\u2013control study","volume":"41","author":"Mishra","year":"2016","journal-title":"Indian J Community Med"},{"key":"10.1016\/j.jgar.2021.11.008_bib0134","article-title":"Behavioral and dietary risk factors of recurrent urinary tract infection in Chinese postmenopausal women: a case\u2013control study","volume":"48","author":"Zhu","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jgar.2021.11.008_bib0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"Schito","year":"2009","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:02Z","timestamp":1761991022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521002599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":135,"alternative-id":["S2213716521002599"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.11.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}